Research map: The Power of Public Science: Lessons from TV003 and Butantan-DV

Back to the article

Papers in this map

  1. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease · Sri Rezeki Hadinegoro · 2015 · 1108 citations · Cited by this paper
  2. Comparative Evaluation of E6/E7 mRNA Expression and Viral DNA Load in Cervical Lesions With Multiple High-Risk Human Papillomavirus Infection · 2026 · Related
  3. Global burden for dengue and the evolving pattern in the past 30 years · Xiaorong Yang · 2021 · 329 citations · Cited by this paper
  4. Diverse Genetic Lineages Spreading Across Healthcare and Community Boundaries Underlie Extended-Spectrum Cephalosporin-Resistant Enterobacterales Colonization Burden in Botswana · 2026 · Related
  5. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. · Anna P. Durbin · 2001 · 300 citations · Cited by this paper
  6. Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation · 2026 · Related
  7. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model · Beth D. Kirkpatrick · 2016 · 270 citations · Cited by this paper
  8. Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis · 2026 · Related
  9. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial · Vianney Tricou · 2024 · 261 citations · Cited by this paper
  10. Characterization of hepatitis B virus in blood donors who were disqualified based on testing: genotype distribution, infectivity, and replicative fitness in human hepatocytes · 2026 · Related
  11. Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults · Beth D. Kirkpatrick · 2015 · 209 citations · Cited by this paper
  12. Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age · 2026 · Related
  13. A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial · Anna P. Durbin · 2013 · 174 citations · Cited by this paper
  14. Shortening HCV Treatment in US Jails: Opportunities and Implementation Considerations · 2026 · Related
  15. rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers · Anna P. Durbin · 2005 · 125 citations · Cited by this paper
  16. Neutralization Capacity Against SARS-CoV-2 Ancestral, Delta, and Omicron Variants Before and After Heterologous Booster Vaccination in Fijian Healthcare Workers · 2026 · Related
  17. Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine · Anna P. Durbin · 2011 · 120 citations · Cited by this paper
  18. Watching the Ship, Missing the Forest: Why Ecological Spillover, Reservoir Ecology, and Environmental Change Remain the True Hantavirus Threats in North America · 2026 · Related
  19. In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination · Stephen S. Whitehead · 2017 · 108 citations · Cited by this paper
  20. Sampling and Host–Strain Interactions Shape Detection of Staphylococcus aureus Transmission in Hospitals · 2026 · Related
  21. rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults · Anna P. Durbin · 2006 · 101 citations · Cited by this paper
  22. The Live Attenuated Dengue Serotype 1 Vaccine rDEN1Δ30 is Safe and Highly Immunogenic in Healthy Adult Volunteers · Anna P. Durbin · 2006 · 95 citations · Cited by this paper
  23. Effects of high temperatures and heatwaves on dengue fever: a systematic review and meta-analysis · Yohannes Tefera Damtew · 2023 · 94 citations · Cited by this paper
  24. The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis · Zhihui Li · 2021 · 86 citations · Cited by this paper
  25. A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans · Usha K. Nivarthi · 2021 · 76 citations · Cited by this paper
  26. A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response · Anna P. Durbin · 2016 · 71 citations · Cited by this paper
  27. A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial · Anna P. Durbin · 2011 · 46 citations · Cited by this paper
  28. Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers · Peter F. Wright · 2009 · 41 citations · Cited by this paper
  29. Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study · Otavio Ranzani · 2025 · 22 citations · Cited by this paper
  30. Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine · Esper Georges Kallas · 2026 · 19 citations · Cited by this paper
  31. Brazil develops and rolls out single-dose dengue vaccine · Manjulika Das · 2026 · 2 citations · Cited by this paper
  32. Untitled · Cited by this paper

Source: OpenAlex (CC0)